Pediapharm Inc. | Cash Flow
Fiscal year is April-March. All values CAD Thousands.
2014
2015
2016
2017
2018
Net Income before Extraordinaries
4,079.60
4,998.90
2,299.30
1,831.90
3,482.60
Depreciation, Depletion & Amortization
111.70
117.10
147.30
51.90
231.20
Other Funds
1,923.00
665.70
1,248.60
745.30
310.20
Funds from Operations
2,044.90
4,216.20
903.40
1,034.70
2,941.30
Changes in Working Capital
34.60
344.40
382.90
223.50
920.60
Net Operating Cash Flow
2,010.30
4,560.60
1,286.30
1,258.30
3,861.80
Capital Expenditures
135.60
911.20
659.10
442.10
727.70
Sale of Fixed Assets & Businesses
178.30
-
-
-
-
Purchase/Sale of Investments
50.50
-
-
-
-
Net Investing Cash Flow
93.20
911.20
659.10
442.10
727.70
Issuance/Reduction of Debt, Net
254.80
5,193.50
4.30
-
-
Net Financing Cash Flow
8,409.80
5,193.50
88.20
-
4,957.00
Net Change in Cash
6,492.70
293.50
1,857.30
1,700.40
367.40
Free Cash Flow
2,022.10
4,615.10
1,290.10
1,261.70
3,870.30
Change in Capital Stock
8,155.00
-
92.50
-
4,957.00
Exchange Rate Effect
-
15.20
-
-
-
About Pediapharm
View Profile
